Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand

Viatris

Status and phase: Completed; Phase 4

Conditions: Dyslipidemias

Treatments: Drug: Atorvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00647543

A2581111

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of atorvastatin in lowering cholesterol on patients from Thailand with high cholesterol.

Enrollment: 242 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Dyslipidemic patients who were eligible for lipid lowering therapy
• Willingness to follow study diet for 1 month prior to screening and for the duration of the study

Exclusion criteria

• Use of other lipid lowering agents (6-week washout period)
• Uncontrolled high blood pressure
• Impaired liver function

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

242 participants in 3 patient groups

High Risk

Experimental group

Treatment:

Drug: Atorvastatin

Drug: Atorvastatin

Drug: Atorvastatin

Low Risk

Experimental group

Treatment:

Drug: Atorvastatin

Drug: Atorvastatin

Drug: Atorvastatin

Medium Risk

Experimental group

Treatment:

Drug: Atorvastatin

Drug: Atorvastatin

Drug: Atorvastatin